Industry / Czech Republic
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Zentiva To Develop Generic Viagra
May 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Czech pharmaceutical company Zentiva is developing a generic form of Eli Lilly's erectile dysfunction (ED) drug Viagra (sildenafil) to be sold in its existing markets. Zentiva, the fourth largest drugmaker from Central and Eastern Europe (CEE), has a dominant position in the Czech and Slovak markets, as well as achieving sales of over CZK1bn (US$61.3mn) in Turkey, Romania and Russia. The company's core business is developing generic drugs, so the successful production and marketing of sildenafil would represent a major